Skip to main content

Table 3 Comparison between the studied groups according to laboratory results

From: Neuropsychiatric lupus erythematosus in a cohort of Egyptian patients

 

Group I (n = 68)

Group II (n = 66)

p

ANA

67 (98.5%)

63 (95.5%)

0.362

Anti-DNA

42 (61.8%)

44 (66.7%)

0.554

C3 Dec

23 (33.8%)

35 (53%)

0.025*

C4 Dec

18 (26.5%)

32 (48.5%)

0.008*

ACL IgG

11 (16.2%)

5 (7.6%)

0.125

ACL IgM

11 (16.2%)

5 (7.6%)

0.125

Lupus anticoagulant

8 (11.8%)

1 (1.5%)

FEp = 0.033*

Anti β 2 GP 1 IgG

1 (1.5%)

0 (0%)

FEp = 1.000

Anti β 2 GP 1 IgM

1 (1.5%)

0 (0%)

FEp = 1.000

Anti-Smith

2 (2.9%)

2 (3%)

FEp = 1.000

Anemia

49 (72.1%)

43 (65.2%)

0.389

Leuco-penia

24 (35.3%)

20 (30.3%)

0.539

Lympho-penia

17 (25%)

16 (24.2%)

0.919

Neutro-penia

5 (7.4%)

4 (6.1%)

1.000

Thrombo-cytopenia

12 (17.6%)

8 (12.1%)

0.369

Proteinuria

39 (57.4%)

41 (62.1%)

0.574

  1. Anti-dsDNA Anti-double stranded DNA antibodies, ANA antinuclear antibody, C3 Complement 3, C4, ACL anticardiolipin, Anti β 2 GP 1 anti β 2 glycoprotein I
  2. χ2: Chi square test; FE: Fisher Exact
  3. p: p value for comparing between the studied groups